| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/17476348.2016.1162715 |
| P8608 | Fatcat ID | release_e42v2eiivnhaja7pnzmhvxld4m |
| P698 | PubMed publication ID | 26949990 |
| P50 | author | Rebecca E Stockwell | Q57052741 |
| Timothy J. Kidd | Q42831844 | ||
| Scott Bell | Q43545877 | ||
| P2093 | author name string | K A Ramsay | |
| P2860 | cites work | Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry | Q22305306 |
| Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak | Q22306482 | ||
| Infections caused by Scedosporium spp. | Q24657691 | ||
| Stenotrophomonas maltophilia: an emerging global opportunistic pathogen | Q26995336 | ||
| Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus | Q45411110 | ||
| A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan | Q45786860 | ||
| Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children | Q45880975 | ||
| Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience | Q46436058 | ||
| Risk factors and causative organisms in microbial keratitis | Q46774915 | ||
| What is the importance of classifying Aspergillus disease in cystic fibrosis patients? | Q46888963 | ||
| Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients | Q46910359 | ||
| Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. | Q46933712 | ||
| Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants | Q48062294 | ||
| Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance | Q49081215 | ||
| Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. | Q51015868 | ||
| Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. | Q51711090 | ||
| Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. | Q53297625 | ||
| Effect of culture conditions on the resistance of Pseudomonas aeruginosa biofilms to disinfecting agents. | Q53689318 | ||
| Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. | Q53900736 | ||
| Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. | Q54541142 | ||
| Cystic fibrosis | Q55881299 | ||
| Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients | Q59139106 | ||
| Anonymous mycobacteria in pulmonary disease | Q28184336 | ||
| Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples | Q28202427 | ||
| Seasonal variations of indoor microbial exposures and their relation to temperature, relative humidity, and air exchange rate | Q28390961 | ||
| Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries | Q28729217 | ||
| Invasive fungal infections after natural disasters | Q30763683 | ||
| Pseudomonas aeruginosa population structure revisited | Q30913394 | ||
| Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources | Q30931813 | ||
| Burkholderia and emerging pathogens in cystic fibrosis | Q30998871 | ||
| Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river | Q33216771 | ||
| Diversity and occurrence of Burkholderia spp. in the natural environment. | Q33329214 | ||
| A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia | Q33726691 | ||
| Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi | Q33792765 | ||
| The changing microbial epidemiology in cystic fibrosis | Q33825634 | ||
| Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis | Q33827090 | ||
| Differential habitat use and niche partitioning by Pseudomonas species in human homes | Q33876648 | ||
| Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. | Q33950924 | ||
| Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. | Q33956730 | ||
| Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study | Q34085781 | ||
| Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis | Q34130445 | ||
| Microbiology of acute otitis externa | Q34143706 | ||
| Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis | Q34372132 | ||
| Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. | Q34412265 | ||
| Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population | Q34425638 | ||
| Continental-scale distributions of dust-associated bacteria and fungi. | Q34473185 | ||
| Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia | Q34678540 | ||
| The hospital water supply as a source of nosocomial infections: a plea for action | Q34714383 | ||
| Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia | Q34982469 | ||
| Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients | Q35094033 | ||
| Diversity and dynamics of airborne fungi in São Luis, State of Maranhão, Brazil. | Q35113076 | ||
| Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor | Q35127240 | ||
| New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. | Q35188869 | ||
| Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease | Q35193554 | ||
| Diversity and significance of Burkholderia species occupying diverse ecological niches. | Q35200150 | ||
| Summer Peaks in the Incidences of Gram-Negative Bacterial Infection Among Hospitalized Patients | Q40025289 | ||
| Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis | Q40960703 | ||
| Geographic variations in cystic fibrosis: An analysis of the U.S. CF Foundation Registry | Q41137775 | ||
| Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark | Q41145157 | ||
| Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis | Q41259608 | ||
| Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years | Q41560657 | ||
| Pseudomonas aeruginosa in CF and non-CF homes is found predominantly in drains | Q41638640 | ||
| Nontuberculous mycobacteria, fungi, and opportunistic pathogens in unchlorinated drinking water in The Netherlands | Q41854088 | ||
| Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans | Q41886330 | ||
| Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates | Q42089409 | ||
| Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center | Q42130118 | ||
| Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients | Q42279891 | ||
| Haemophilus influenzae and the lung (Haemophilus and the lung). | Q43212173 | ||
| Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres | Q43644594 | ||
| Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis | Q43721825 | ||
| Bacterial community of biofilms developed under different water supply conditions in a distribution system. | Q43726391 | ||
| Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition | Q43745855 | ||
| Increasing nontuberculous mycobacteria infection in cystic fibrosis | Q44189223 | ||
| Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact | Q44252772 | ||
| Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. | Q44477142 | ||
| Prevalence, persistence, and phenotypic variation of Aspergillus fumigatus in the outdoor environment in Manchester, UK, over a 2-year period | Q44567268 | ||
| Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis | Q44656924 | ||
| Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. | Q45029608 | ||
| Massive hemoptysis in cystic fibrosis | Q45093448 | ||
| Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis | Q35535652 | ||
| Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. | Q35536357 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis | Q35604702 | ||
| An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis | Q35802333 | ||
| Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections | Q35804472 | ||
| Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA | Q35877520 | ||
| Spatial clusters of nontuberculous mycobacterial lung disease in the United States | Q36345297 | ||
| Environmental factors that affect the survival and persistence of Burkholderia pseudomallei | Q36596229 | ||
| Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort | Q36673569 | ||
| The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections | Q36750086 | ||
| The effect of season and weather on physical activity: a systematic review | Q36963251 | ||
| Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis | Q37334924 | ||
| Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment | Q37396516 | ||
| Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis | Q37463364 | ||
| Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology | Q37688257 | ||
| Impact of human activities on the ecology of nontuberculous mycobacteria | Q37762557 | ||
| Travelling with cystic fibrosis: Recommendations for patients and care team members | Q37789930 | ||
| Link between CFTR mutations and ABPA: a systematic review and meta-analysis | Q37945665 | ||
| Staphylococcus aureus: determinants of human carriage | Q38101786 | ||
| Paediatric community-associated Staphylococcus aureus: a retrospective cohort study | Q38110584 | ||
| Electrolyte abnormalities in cystic fibrosis: systematic review of the literature | Q38170270 | ||
| Management of comorbidities in older patients with cystic fibrosis. | Q38178773 | ||
| Respiratory infections in travelers returning from the tropics. | Q38266257 | ||
| Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience | Q38283021 | ||
| Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment | Q38341053 | ||
| Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation | Q38419604 | ||
| The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates | Q38898519 | ||
| Future trends in cystic fibrosis demography in 34 European countries | Q39027112 | ||
| Human and planetary health: towards a common language | Q39279461 | ||
| Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis | Q39290648 | ||
| Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. | Q39486666 | ||
| Changes in concentration of Alternaria and Cladosporium spores during summer storms | Q39518334 | ||
| Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. | Q39653993 | ||
| P433 | issue | 5 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 505-519 | |
| P577 | publication date | 2016-03-28 | |
| P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
| P1476 | title | Infection in cystic fibrosis: impact of the environment and climate | |
| P478 | volume | 10 |
| Q40105439 | Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis |
| Q38764394 | Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis |
| Q57812471 | Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations |
Search more.